Delay in Insurance Approval of Biologic Therapy Dose Escalation Is Associated With Increased Disease Activity in Patients With Inflammatory Bowel Disease

被引：0
|
作者：
Shah, Nisha [1 ]
Cherry, Laura [1 ]
Zuckerman, Autumn [1 ]
Vimalathas, Praveen [1 ]
Choi, Leena [1 ]
Donoho, Charles A. [1 ]
Pabla, Baldeep [1 ]
Scoville, Elizabeth [1 ]
Dalal, Robin [1 ]
Beaulieu, Dawn [1 ]
Schwartz, David [1 ]
Horst, Sara [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S833
引用
收藏
页码：S385 / S385
页数：1
相关论文
共 50 条
  • [1] Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease
    Nisha B. Shah
    Autumn D. Zuckerman
    Katie R. Hosteng
    Jessica Fann
    Josh DeClercq
    Leena Choi
    Laura Cherry
    David A. Schwartz
    Sara Horst
    Digestive Diseases and Sciences, 2023, 68 : 4331 - 4338
  • [2] Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease
    Shah, Nisha B.
    Zuckerman, Autumn D.
    Hosteng, Katie R.
    Fann, Jessica
    Declercq, Josh
    Choi, Leena
    Cherry, Laura
    Schwartz, David A.
    Horst, Sara
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (12) : 4331 - 4338
  • [3] IDENTIFICATION OF DOSE-ESCALATION IN BIOLOGIC THERAPY BASED ON CLAIMS DATA: THE EXAMPLE OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Groth, A.
    Brandes, A.
    Fuchs, A.
    Deiters, B.
    Ratsch, B.
    Wilke, T.
    Bokemeyer, B.
    VALUE IN HEALTH, 2018, 21 : S356 - S356
  • [4] EFFECTIVENESS OF DOSE DE-ESCALATION OF BIOLOGIC THERAPY IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW
    Little, Derek H.
    Tabatabavakili, Sahar
    Shaffer, Seth
    Weizman, Adam V.
    Nguyen, Geoffrey C.
    Targownik, Laura E.
    GASTROENTEROLOGY, 2020, 158 (06) : S670 - S671
  • [5] Effectiveness of Dose De-escalation of Biologic Therapy in Inflammatory Bowel Disease: A Systematic Review
    Little, Derek H. W.
    Tabatabavakili, Sahar
    Shaffer, Seth R.
    Nguyen, Geoffrey C.
    Weizman, Adam, V
    Targownik, Laura E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (11): : 1768 - 1774
  • [6] Biologic Therapy Is Not Associated With Increased Risk of Cancer or Infection in Elderly Patients With Inflammatory Bowel Disease
    Chan, Jennifer
    Roy, Abhik
    Wade, Elijah
    Tucker, Lue-Yen
    Velayos, Fernando
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S949 - S949
  • [7] De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation
    Thomas, Pepijn W. A.
    Smits, Lisa J. T.
    Te Groen, Maarten
    West, Rachel L.
    Russel, Maurice G. V. M.
    Jansen, Jeroen M.
    Romkens, Tessa E. H.
    Hoentjen, Frank
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (05) : 488 - 495
  • [8] Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease
    Abadir, Alexander
    Troia, Angela
    Said, Hyder
    Tarugu, Spurthi
    Billingsley, Benjamin C.
    Sairam, Nathan
    Minchenberg, Scott B.
    Owings, Anna H.
    Parker, Adam M.
    Brousse, Brandon
    Carlyle, Alexander
    Owens, Bobby R.
    Hosseini-Carroll, Pegah
    Galeas-Pena, Michelle
    Frasca, Joseph
    Glover, Sarah C.
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (08) : 2796 - 2803
  • [9] Biologic Therapy in Inflammatory Bowel Disease
    Theede, Klaus
    Dahlerup, Jens Frederik
    Fallingborg, Jan
    Hvas, Christian Lodberg
    Kjeldsen, Jens
    Munck, Lars Kristian
    Nordgaard-Lassen, Inge
    DANISH MEDICAL JOURNAL, 2013, 60 (06):
  • [10] Biologic therapy of inflammatory bowel disease
    Sandborn, WJ
    Targan, SR
    GASTROENTEROLOGY, 2002, 122 (06) : 1592 - 1608
12345